Prism Medico & PharmacyBOM:512217 53 Forward Dividend Yield % is 0.00% as of Jul. 11, 2026. GuruFocus rates BOM:512217 with a GF Score™ of 53/100 and a GF Value™ of ₹27.40 (Fairly Valued). The stock has 4 warning signs investors should review. Among 1,151 Consumer Packaged Goods companies, Prism Medico & Pharmacy ranks worse than 86880.89% on this metric.
As of today (2026-07-11), the Forward Annual Dividend Yield of Prism Medico & Pharmacy is 0.00%.
As of today (2026-07-11), the Trailing Annual Dividend Yield of Prism Medico & Pharmacy is 0.00%.
BOM:512217's Forward Dividend Yield % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 3.03 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Prism Medico & Pharmacy Forward Dividend Yield % Related Terms
BOM:512217 vs ADM, BG, TSN: Forward Dividend Yield % Comparison
For the Farm Products subindustry, Prism Medico & Pharmacy's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prism Medico & Pharmacy Forward Dividend Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Prism Medico & Pharmacy's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Prism Medico & Pharmacy's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Prism Medico & Pharmacy (BOM:512217) has a Forward Dividend Yield % of 0.00% as of Jul. 11, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Prism Medico & Pharmacy and its competitors. According to the industry distribution chart, Prism Medico & Pharmacy ranks #999999 out of 1151 companies in the Consumer Packaged Goods industry.
Is Prism Medico & Pharmacy's Forward Dividend Yield % too high?
Prism Medico & Pharmacy's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Prism Medico & Pharmacy ranks #999999 out of 1151 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Prism Medico & Pharmacy has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Prism Medico & Pharmacy's Forward Dividend Yield % compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Prism Medico & Pharmacy ranks #999999 out of 1151 companies for Forward Dividend Yield %. This places Prism Medico & Pharmacy in the lower half of its industry. The industry median Forward Dividend Yield % is 3.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Consumer Packaged Goods company?
The median Forward Dividend Yield % among Consumer Packaged Goods companies is 3.03, based on 1,151 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Prism Medico & Pharmacy and its competitors. For the Consumer Packaged Goods industry, the median Forward Dividend Yield % is 3.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prism Medico & Pharmacy's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prism Medico & Pharmacy stock overvalued right now?
Based on GuruFocus' analysis, Prism Medico & Pharmacy (BOM:512217) is currently considered Fairly Valued. The stock's GF Value™ is ₹27.40, compared to a current price of ₹28.80 — trading 5.1% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. Prism Medico & Pharmacy's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Prism Medico & Pharmacy (BOM:512217), the current Forward Dividend Yield % is 0.00% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prism Medico & Pharmacy (BOM:512217) Overvalued in 2026?
Based on GuruFocus' analysis, Prism Medico & Pharmacy stock appears to be overvalued.
The current stock price of ₹28.80 is trading 5.1% above its estimated GF Value™ of ₹27.40.
GuruFocus considers Prism Medico & Pharmacy to be Fairly Valued.
Key valuation signals for BOM:512217:
Forward Dividend Yield %: 0.00%
GF Value™: ₹27.40 vs. price of ₹28.80 (5.1% above fair value)
No single metric tells the full story. See the BOM:512217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prism Medico & Pharmacy Ltd operates in the wholesale and retail of animal feed, poultry feed, cattle feed, aqua feed, ayurvedic foods, organic food, juices, cosmetics, herbal extracts, nutrients, and FMCG products. The company generates the majority of its revenue from the sale of agricultural products.
53GF Score
Get the complete analysis for BOM:512217
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:512217 has been successfully added to your 